Concession brevetto VEI_05 ITA

Patent granted on revolutionary invention for treatment of visual disorders

We are pleased to announce that the Italian Patent and Trademark Office has granted Vision Engineering Italy srl the industrial invention patent no. 102019000010341 entitled “Device, system and method of treatment of a corneal tissue”.

The patent protects a novel invention of the Company that has developed a cutting-edge surgical platform for the correction of visual disorders. The invention revolutionizes current methods for correcting ocular refractive disorders, which are  based on the use of lasers, by introducing a novel treatment paradigm that improves vision without incisions of the corneal tissue. Vision Engineering Italy eliminates risks and improves the standard of care for visual disorders to an unprecedented level.

Brevetti+ 2

Vision Engineering Italy awarded by Brevetti+2 grant

We are pleased to announce that Vision Engineering Italy srl is the first company to win the “Brevetti+” tender twice.

“Brevetti+” is the incentive for sustaining the economic growth of patents, promoted by the Ministry of Economic Development and managed by Invitalia SpA.

This second grant is awarded to Vision Engineering Italy for the development of a new medical device for the correction of visual disorders by exploiting the revolutionary proprietary paradigm of theranostics.




Il Progetto Chromo4Vis riceve il contributo Brevetti+ da Invitalia

Vision Engineering Italy è lieta di comunicare che il progetto di industrializzazione di Chromo4Vis è stato selezionato da Invitalia Spa tra i vincitori del bando Brevetti +. Il contributo è concesso per la valorizzazione del brevetto “apparato di controllo del dosaggio di un agente cromoforo in un tessuto corneale e procedimento per dosare un agente cromoforo in un tessuto corneale” cui fa capo l’innovativo dispositivo medico di teranostica Chromo4Vis per la cura personalizzata del cheratocono. Grazie all’agevolazione, Vision Engineering Italy completerà l’industrializzazione del prodotto per la certificazione CE.

copertina Graefe

New evidences on efficacy of Chromo4Vis

The third paper on our breakthrough technology has been recently e-published on Graefes Arch Clin Exp Ophthalmol.  It can downloaded at the researchgate webiste.

Chromo4Vis assists the surgeon to obtain the most effective intended outcome regardless of the procedures used during corneal cross-linking.

Learn about theranostics and the future of image-guided corneal cross-linking for precise therapy of keratoconus and corneal ectasia.

Vision Engineering Italy is innovating eye care with smart solutions!

foto Marco sala 1

Preclinical results on the innovative image-guided corneal cross-linking for keratoconus

Dr. Marco Lombardo will present the preclinical results on efficacy of Chromo4Vis at the VIII “Segmant” Course on diagnostics and therapy of keratoconus that will be held in Naples on September 27th 2019.

Chromo4Vis is the first medical device for the personalized treatment of keratoconus; it will provide surgeons with image-guided corneal cross-linking to tailor treatment to each patient and to achieve 100% efficacy and safety for all!

The Course will be held at the Monaldi Hospital in Naples from 9.00 am to 4.00 pm on Friday 27th September.

Premio Lazio 2030

Vision Engineering Italy awarded by Lazio region

Vision Engineering Italy awarded as one of the most innovative firms in Lazio region. The award has been given to the co-founders and brothers, Marco and Giuseppe Lombardo.

Vision Engineering Italy has patented and developed the first available theranostic medical device for treating one of major eye disorders, keratoconus, which is the primary cause of corneal transplant worlwide.

“Research and innovation is our conscious choice to create value in our Country” the founders commented during the award ceremony.